New low-volume resuscitation solutions containing PEG-20k

Area of Science:

• Resuscitation medicine
• Shock management
• Biomedical engineering

Background:

• Hypovolemic shock impairs oxygen delivery and cell volume regulation, leading to microcirculatory dysfunction.
• Cell swelling exacerbates reduced oxygen exchange, highlighting the importance of cell impermeants in resuscitation.
• Effectiveness of cell impermeants in acute studies prompted investigation in survival models.

Purpose of the Study:

• To evaluate the efficacy of impermeants, specifically polyethylene glycol-20k (PEG-20k), in survival models of hypovolemic shock.
• To compare PEG-20k-based low-volume resuscitation (LVR) solutions with conventional crystalloid solutions.

Main Methods:

• Adult rats were subjected to controlled hemorrhage to induce hypovolemic shock.
• LVR solutions containing varying concentrations of PEG-20k, Hextend, or albumin were administered.
• Resuscitation success was measured by LVR time, survival rates, and laboratory values.

Main Results:

• 10% PEG-20k significantly increased LVR times (eightfold) compared to saline, Hextend, and albumin.
• PEG-20k maintained normal arterial pressure during the low-volume state.
• Survival rates reached 100% with PEG-20k during a 180-minute LVR challenge, versus 0% for saline controls.

Conclusions:

• PEG-20k-based LVR solutions demonstrate high efficacy in improving survival during hypovolemic shock.
• PEG-20k confers tolerance to the low-volume state, offering a promising resuscitation strategy.